Support independent, student-run journalism.

Your support helps give staff members from all backgrounds the opportunity to conduct meaningful reporting on important issues at Stanford. All contributions are tax-deductible.

Stanford researchers develop new, ‘three-dimensional’ CRISPR technology

On Thursday, a team led by assistant professor of bioengineering Stanley Qi released a study on a new form of gene-editing technology known as Clustered Regularly Interspaced Short Palindromic Repeats genome organization, or CRISPR-GO, which allows scientists to move pieces of DNA within a cell nucleus. In contrast, previous CRISPR technology has been used to “cut” and “paste” sections of the genetic code within individual pieces of DNA.

Laboratory for Cell and Gene Medicine opens in Palo Alto

Stanford’s Laboratory for Cell and Gene Medicine (LCGM), the university’s first manufacturing facility specifically designed to adhere to the Food and Drug Administration’s (FDA’s) current good manufacturing practices (CGMPs), opened this month in Palo Alto.

This recent partnership between the Stanford School of Medicine, Stanford Health Care and Stanford Children’s Health is dedicated towards developing biological products for phase-1 and phase-2 clinical trials.